Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases
Go back to Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases| StemCells, Inc. (NASDAQ: TEM) | Delayed: 62.17 -5.59 (8.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.76 | 52 Week High | $0.45 | |||
| Open | $66.10 | 52 Week Low | $0.37 | |||
| Day High | $68.29 | P/E | N/A | |||
| Day Low | $61.51 | EPS | $-0.31 | |||
| Volume | 3,722,114 | |||||



